Eli Lilly completes $8bn acquisition of Loxo Oncology to expand oncology portfolio

Eli Lilly and Company, the US-based pharmaceutical giant, has finalised its $8 billion acquisition of Connecticut-based biopharmaceutical firm Loxo Oncology, a move expected to significantly ... Read More